Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Dittrich

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Wiener Medizinische Wochenschrift (1946)|April 23, 2003
[Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors]Eva S Schernhammer, Christian Dittrich
AJR. American Journal of Roentgenology|April 15, 2026
Paramagnetic Rim Lesions as Prognostic Biomarkers for the Development of Multiple Sclerosis in Radiologically Isolated SyndromeMaximilian Christian Dittrich, Susie Y Huang
Soft Matter|July 19, 2020
Biomimetic membranes designed from amphiphilic block copolymersAlmut Mecke, Christian Dittrich, Wolfgang Meier
Oncology (Williston Park, N.Y.)|January 20, 2005
Overview of phase I/II pemetrexed studiesAxel R Hanauske, Christian Dittrich, Jorge Otero
Biomaterials|January 10, 2012
Delivery of membrane impermeable cargo into CHO cells by peptide nanoparticles targeted by a protein coronaChristian Dittrich, Christoph J Burckhardt, Gaudenz Danuser
Melanoma Research|September 22, 2007
Clinical complete long-term remission of a patient with metastatic malignant melanoma under therapy with indisulam (E7070)Martina Baur, Margit Gneist, Takashi Owa, et al.
Oncotarget|April 9, 2016
Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptorsJürgen Borlak, Florian Länger, Reinhard Spanel, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2007
Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunctionMartina Baur, Anne Drescher, Margit Gneist, et al.
Radiology and Oncology|July 4, 2014
Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumabRobert Königsberg, Julia Maierhofer, Tanja Steininger, et al.
Anticancer Research|March 14, 2013
Validation of a simple assay for the quantification of the capecitabine metabolites 5'-DFCR and 5'-DFUR for drug monitoring in patients receiving outpatient chemotherapyPhilipp Buchner, Eva Mihola, Azra Sahmanovic, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Wiener Medizinische Wochenschrift (1946)|April 23, 2003
[Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors]Eva S Schernhammer, Christian Dittrich
AJR. American Journal of Roentgenology|April 15, 2026
Paramagnetic Rim Lesions as Prognostic Biomarkers for the Development of Multiple Sclerosis in Radiologically Isolated SyndromeMaximilian Christian Dittrich, Susie Y Huang
Soft Matter|July 19, 2020
Biomimetic membranes designed from amphiphilic block copolymersAlmut Mecke, Christian Dittrich, Wolfgang Meier
Oncology (Williston Park, N.Y.)|January 20, 2005
Overview of phase I/II pemetrexed studiesAxel R Hanauske, Christian Dittrich, Jorge Otero
Biomaterials|January 10, 2012
Delivery of membrane impermeable cargo into CHO cells by peptide nanoparticles targeted by a protein coronaChristian Dittrich, Christoph J Burckhardt, Gaudenz Danuser
Melanoma Research|September 22, 2007
Clinical complete long-term remission of a patient with metastatic malignant melanoma under therapy with indisulam (E7070)Martina Baur, Margit Gneist, Takashi Owa, et al.
Oncotarget|April 9, 2016
Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptorsJürgen Borlak, Florian Länger, Reinhard Spanel, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2007
Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunctionMartina Baur, Anne Drescher, Margit Gneist, et al.
Radiology and Oncology|July 4, 2014
Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumabRobert Königsberg, Julia Maierhofer, Tanja Steininger, et al.
Anticancer Research|March 14, 2013
Validation of a simple assay for the quantification of the capecitabine metabolites 5'-DFCR and 5'-DFUR for drug monitoring in patients receiving outpatient chemotherapyPhilipp Buchner, Eva Mihola, Azra Sahmanovic, et al.
Pageof 8